The incorrect conclusion about vaginally administered progesterone: when a randomized clinical trial gets it wrong

Richard J. Paulson
F&S reports · 2024 · vol. 5(4) , pp. 339–340 · doi:10.1016/j.xfre.2024.11.003 · PMID:39781067 · PMC11705577 · W4404195335
Other OA: gold CC0
📄 Open PDF View on OpenAlex View on PubMed View at publisher
⚙ AI-generated summary by gemini-2.5-flash-lite, 2026-06-13 ⓘ

This paper critiques a randomized clinical trial's conclusion regarding vaginally administered progesterone, arguing that the trial's methodology led to an incorrect interpretation of the results.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

Abstract

The incorrect conclusion about vaginally administered progesterone: when a randomized clinical trial gets it wrong

My notes (saved in your browser only)

Citation neighborhood (no data yet)

We don't have any in-corpus citations linked to this paper yet. This is a recent paper (2024) — citers typically take a year or two to land, and the OpenAlex reference graph may still be filling in.

References (5)

Source provenance

openalex
last seen: 2026-06-10T17:14:06.276822+00:00
pubmed
last seen: 2026-10-08T21:47:24.756528+00:00
License: CC0 · commercial use OK